Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yunnan Baiyao Plaster for Joint Pain in Active Rheumatoid Arthritis
ChiCTR2600123200Phase 4Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Apr 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Yunnan Baiyao Plaster with Placebo Yunnan Baiyao Plaster (2 arms). Primary endpoint: Change in resting VAS pain score at target joint at Week 2. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
Yunnan Baiyao Plaster
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR2600123200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123200.